amlodipine, valsartan and hydrochlorothiazide
Generic: amlodipine, valsartan and hydrochlorothiazide
Labeler: aurobindo pharma limitedDrug Facts
Product Profile
Brand Name
amlodipine, valsartan and hydrochlorothiazide
Generic Name
amlodipine, valsartan and hydrochlorothiazide
Labeler
aurobindo pharma limited
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
amlodipine besylate 5 mg/1, hydrochlorothiazide 25 mg/1, valsartan 160 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
65862-835
Product ID
65862-835_a583a371-730c-4f0a-86b6-01e654770f16
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA206180
Listing Expiration
2026-12-31
Marketing Start
2017-12-19
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65862835
Hyphenated Format
65862-835
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
amlodipine, valsartan and hydrochlorothiazide (source: ndc)
Generic Name
amlodipine, valsartan and hydrochlorothiazide (source: ndc)
Application Number
ANDA206180 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
- 25 mg/1
- 160 mg/1
Packaging
- 500 TABLET, FILM COATED in 1 BOTTLE (65862-835-05)
- 30 TABLET, FILM COATED in 1 BOTTLE (65862-835-30)
- 90 TABLET, FILM COATED in 1 BOTTLE (65862-835-90)
Packages (3)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a583a371-730c-4f0a-86b6-01e654770f16", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "upc": ["0365862836304", "0365862835307", "0365862837301", "0365862834300"], "unii": ["0J48LPH2TH", "864V2Q084H", "80M03YXJ7I"], "rxcui": ["848131", "848135", "848140", "848145", "848151"], "spl_set_id": ["6fba5243-ee00-4825-a04a-321cb6b49c56"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (65862-835-05)", "package_ndc": "65862-835-05", "marketing_start_date": "20171219"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (65862-835-30)", "package_ndc": "65862-835-30", "marketing_start_date": "20171219"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (65862-835-90)", "package_ndc": "65862-835-90", "marketing_start_date": "20171219"}], "brand_name": "Amlodipine, Valsartan and Hydrochlorothiazide", "product_id": "65862-835_a583a371-730c-4f0a-86b6-01e654770f16", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "65862-835", "generic_name": "Amlodipine, Valsartan and Hydrochlorothiazide", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine, Valsartan and Hydrochlorothiazide", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "VALSARTAN", "strength": "160 mg/1"}], "application_number": "ANDA206180", "marketing_category": "ANDA", "marketing_start_date": "20171219", "listing_expiration_date": "20261231"}